News
3d
MedPage Today on MSNRFK Jr.'s Purge of FOIA Staff at FDA Spares People Working on COVID Vaccine LawsuitsMass firings at the FDA have decimated divisions tasked with releasing public records generated by the agency's regulatory ...
As the Trump administration cuts thousands of federal jobs, some fired workers worry about health agencies' ability to ...
Hosted on MSN11d
FDA delays full approval of Novavax Covid-19 vaccine even though it was on track for clearanceBut with FDA action, it would be the third vaccine against Covid-19 to receive full FDA approval. Full approval would make ...
Dr. Peter Marks, an ex-FDA vaccine official, is warning of a fundamental change at the agency—where vaccine skepticism now ...
A person familiar with the situation told CNN that the FDA is seeking more data on the vaccine, which has been available under emergency use authorization since 2022. It was the first Covid-19 ...
The Wall Street Journal on MSN11d
FDA Punts on Major Covid-19 Vaccine Decision After Ouster of Top OfficialThe agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
The Food and Drug Administration is reversing course on its requirement for all staffers to report to the office ...
Novavax's COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request ...
Novavax started the week hoping the FDA would issue a full approval of its Covid vaccine. But the decision never came.
FRIDAY, April 4, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has delayed the full approval of Novavax’s COVID-19 vaccine. The decision had been expected by April 1, but the ...
An episode of the "Joe Rogan Experience" podcast, seen by more than 10 million, appears to have reignited interest in the ...
“We are confident our well-tolerated vaccine represents an important alternative to mRNA Covid-19 vaccines for the US,” Novavax said. The FDA’s press office was put on administrative leave ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results